BiotechTube
Home/CasInvent Pharma/Alexander Scheer
AS

Alexander Scheer

CEO / CSO

CasInvent Pharma

Therapeutic Areas

Oncology

CasInvent Pharma Pipeline

DrugIndicationPhase
CK1 Inhibitor ProgramResistant Acute Myeloid Leukemia (AML), Solid Tumors (PDAC, TNBC, Melanoma, Prostate Cancer)Preclinical

Leadership Team at CasInvent Pharma

VH
Vojtěch Helikar
CFO / COO
KP
Kamil Paruch
Head of Chemistry
TR
Tomasz Radaszkiewicz
Head of Biology
View full CasInvent Pharma profile